Where does Cloudneuro rank among its competitors?

Cloudneuro ranks 8th amongst 8 active competitors, of which 2 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Ampahealth, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Cloudneuro?

Cloudneuro's top competitors include NeuroCare Group, Ampahealth and SYNEIKA. Among them, Ampahealth secured the most recent funding round in May, 2026.

Cloudneuro - 2026 Company Profile & Competitors

Cloudneuro is an unfunded company. It operates as a Provider of neurodiagnostic and neuromodulation medical devices for clinical practices. Cloudneuro has not raised any funding yet. The company has 8 active competitors, including 2 that are funded. Its top competitors include companies like NeuroCare Group, Ampahealth and SYNEIKA.

Company Details

Provider of neurodiagnostic and neuromodulation medical devices for clinical practices. These systems facilitate the diagnosis and treatment of various neurological and psychiatric conditions. Offerings include nerve conduction study equipment, electromyography systems, repetitive transcranial magnetic stimulation devices, and quantitative electroencephalography hardware. Medical professionals utilize these tools to assess and manage neuropathies and mental health disorders within clinical settings. Training resources are provided to assist practitioners in the application of these diagnostic and therapeutic technologies.

Key Metrics

Stage

Unfunded

Ranked

8^th among 8 active competitors

Similar Companies

NeuroCare Group & 6 more

View Cloudneuro's full profile

Cloudneuro has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cloudneuro include NeuroCare Group, Ampahealth and SYNEIKA. Here is the list of Top 10 competitors of Cloudneuro, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroCare Group 2015, Munich (Germany), Series B	Provider of noninvasive neurotechnology and personalized mental healthcare platform	$37M	Palo Santo, Impact Expansion & 59 others	64/100
2nd	Ampahealth Seed	Developer of portable transcranial magnetic stimulation systems for clinical use	$10.5M	Bayshore Global Management, zabarafoundation.com ... & 6 others	39/100
3rd	SYNEIKA 2009, Rennes (France), Unfunded	Developer of Transcranial Magnetic Stimulation devices to alleviate chronic neurological and psychiatric diseases	-	-	26/100
4th	Adaptive Technology 2017, Murfreesboro (United States), Funding Raised	Developer of solutions for cognitive skill training	-	HHS	19/100
5th	Asif New York (United States), Unfunded	Developer of non-invasive neuromodulation techniques for understanding human neurophysiology	-	-	16/100
6th	Neurostimsystems Holten (Netherlands), Unfunded	Provider of multimodal measurement and stimulation systems for clinical neuroscience	-	-	16/100
7th	Electroceuticals Unfunded	Developer of medical devices integrating diagnostic sensors with therapeutic stimulation	-	-	16/100
8th	Cloudneuro Unfunded	Provider of neurodiagnostic and neuromodulation medical devices for clinical practices	-	-	16/100